Form 4: Takeda Pharmaceutical Co Executive Sells Shares
Insider Transaction (Form 4)
Lauren Rusckowski Duprey, Chief Transformation Officer of Takeda Pharmaceutical Co Ltd, sold 47,586 shares of common stock on August 10, 2026 for $17.10 per share.
Summary
- Open-market sale: disposed of 47,586 American Depositary Shares at $17.10 ($813,721) on August 10, 2026; holds 226,057 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $813,721 of stock on the open market.
Insider Transactions
Lauren Rusckowski Duprey — Officer (Chief Transformation Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Open-market sale | American Depositary Shares | 47,586 | $17 | $813.7K | 226,057 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Open-market sale (47,586 shares) |
Keywords
insider transaction, Form 4, TAK, TAKEDA PHARMACEUTICAL CO LTD, bearish, Lauren Rusckowski Duprey
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.